Collective progress in drug delivery

被引:3
作者
Park, Kinam [1 ]
机构
[1] Purdue Univ, Biomed Engn & Pharmaceut, W Lafayette, IN 47907 USA
关键词
D O I
10.1016/j.jconrel.2019.03.023
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:197 / 199
页数:3
相关论文
共 14 条
  • [1] Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
    Boehm, Garth
    Yao, Lixin
    Han, Liang
    Zheng, Qiang
    [J]. ACTA PHARMACEUTICA SINICA B, 2013, 3 (05) : 297 - 311
  • [2] Bremmer I., 2018, US VS THEM FAILURE G, P198
  • [3] Computer-History-Museum, 2019, TIM COMP HIST
  • [4] Dalakov G., 2019, HIST COMPUTERS HARDW
  • [5] David M., 2012, YOU ARE NOT SO SMART, P277
  • [6] FDA, 2006, HIST FDA DRUG REG US
  • [7] FDA, 1984, HATCH WAXM LETT
  • [8] Goldin I., 2016, Age of discovery: Navigating the risks and rewards of our new renaissance
  • [9] Holmes J., 2015, NONSENSE POWER NOT K, P322
  • [10] Lee P.I., 2010, Oral Controlled Release Formulation Design and Drug Delivery, P21